Home > PE Ratio > EVEREST ORGANICS

EVEREST ORGANICS
PE (Price/Earnings) Ratio

The Current P/E Ratio of EVEREST ORGANICS is 63.69.

Share Price ₹407.0Sep 19,2025
Market Cap ₹394.7 Cr
Earnings-TTM₹6.2 CrTTM-Standalone Results
Price/Earnings63.69xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for EVEREST ORGANICS
Please provide your vote to see the results
EVEREST ORGANICS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of EVEREST ORGANICS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of EVEREST ORGANICS is calculated as :

Current Market Cap [ ₹394.7 Cr] as on Sep 19,2025

(/) Earnings [ ₹6.2 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 63.69x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for EVEREST ORGANICS , the investors are currently willing to pay 63.69 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of EVEREST ORGANICS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of EVEREST ORGANICS over the last five years.

Historical PE (Price/Earnings) ratio chart of EVEREST ORGANICS


PE Ratio Performance Analysis for EVEREST ORGANICS

- EVEREST ORGANICS 's latest p/e ratio is 63.69x.

- EVEREST ORGANICS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 160.34x.

- EVEREST ORGANICS 's operated at median p/e ratio of 13.41x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, EVEREST ORGANICS 's p/e ratio peaked in Mar2024 at 659.77x.

- EVEREST ORGANICS 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does EVEREST ORGANICS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
EVEREST ORGANICS 6.2063.69394.7
SUN PHARMACEUTICAL INDUSTRIES LTD10,411.5038.16397,342.0
DIVIS LABORATORIES LTD2,306.0071.36164,555.0
CIPLA LTD5,406.8123.54127,259.0
TORRENT PHARMACEUTICALS LTD2,002.0061.39122,898.0
DR REDDYS LABORATORIES LTD5,726.7019.28110,394.0
MANKIND PHARMA LTD1,905.5157.64109,835.0
ZYDUS LIFESCIENCES LTD4,637.8022.50104,346.0
LUPIN LTD3,722.1825.2393,917.9
AUROBINDO PHARMA LTD3,417.9319.0064,953.9
ABBOTT INDIA LTD1,452.2944.3364,384.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs EVEREST ORGANICS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.00x
Max industry PE 71.36x
Median industry PE 38.16x
Average industry PE 40.56x



You may also like the below Video Courses